A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

Fred Hutchinson Cancer Center (FHCC)

Status: Completed

Conditions: Nicotine Dependence; Nicotine Addiction; Nicotine Vaping; Nicotine Use Disorder; Vaping

Treatments: Other: Text Message; Behavioral: Smartphone app; Other: Survey Administration

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05897242

RG1122763

UG3DA057032 (U.S. NIH Grant/Contract)

NCI-2022-10010 (Registry Identifier)

Details and patient eligibility

About

Almost one in ten young adults report current e-cigarette use, putting them at risk of developing nicotine addiction and long-term health effects of exposure to inhaled toxicants. Despite the need for effective treatments to help these young users quit, very few treatments targeting any type of tobacco use among young adults have been evaluated, particularly for young adults who vape and have unique treatment needs. To address these needs, this trial will evaluate a digital program for young adult e-cigarette users at all stages of readiness to quit called ACT on Vaping.

Full description

OUTLINE:

Participants are randomized to 1 of 2 arms.

ARM I: Participants use the ACT on Vaping smartphone app and text messaging program and receive incentivized text messages assessing their vaping status.

ARM II: Participants receive incentivized text messages check-ins assessing their vaping status.

Enrollment: 61 patients

Sex: All

Ages: 18 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 18-30.
• Current weekly user of e-cigarette product(s).
• Owns an Android phone or iPhone.
• Has an email address.
• United States (US) resident, with a US mailing address.
• Willing to complete all study procedures.

Exclusion criteria

• Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatments is allowable during trial participation).
• Member of the same household as another research participant.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

61 participants in 2 patient groups

Arm I (Act on Vaping app)

Experimental group

Description:

Participants receive supportive messages and use the ACT on Vaping smartphone app. They also receive incentivized text message check-ins assessing their vaping status.

Treatment:

Other: Survey Administration

Behavioral: Smartphone app

Other: Text Message

Arm II (Incentivized text message check-ins)

Active Comparator group

Description:

Participants receive incentivized text messages check-ins assessing their vaping status.

Treatment:

Other: Survey Administration

Other: Text Message